Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Ameet Sarpatwari

Behind $2 million per dose gene therapy

How did a drug rooted in government seed money and spurred by grassroots fundraising end up with such a price tag?

Salon · Feb 19, 2025

White House proposes to 'march in' on patents for costly drugs

To lower drug prices, the Biden administration is looking to assert its authority to license drug patents that rely on government-funded research to drugmakers that would offer cheaper medicines.

WEKU · Dec 7, 2023

Sen. Sanders pushes NIH to rein in drug prices

The National Institutes of Health has been reluctant to use its leverage as a biomedical research funder to influence drug pricing. Sen. Bernie Sanders is pressing NIH's new director to take action.

WEKU · Nov 17, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

Lisa Jarvis: Abortion pill ruling threatens pharmaceutical innovation

A Texas federal judge’s ruling to remove the 23-year-old drug mifepristone from the market not only threatens abortion access in the U.S. — it’s also an appalling sideswipe at the Food and Drug Administration’s authority and expertise.

Tribune News Service · Apr 12, 2023

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

353 stories

Novartis

171 stories

The National Institutes of Health

170 stories

the Department of Health and Human Services

156 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.